• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨苯砜和单乙酰氨苯砜在犬体内的处置(38516)

The disposition of dapsone and monoacetyldapsone in the dog (38516).

作者信息

Peters J H, Gordon R, Biggs J T, Levy L

出版信息

Proc Soc Exp Biol Med. 1975 Jan;148(1):251-5. doi: 10.3181/00379727-148-38516.

DOI:10.3181/00379727-148-38516
PMID:1129265
Abstract

Four female dogs receiving 1.0 mg dapsone (DDS)/kg iv exhibited logarithmic decline of plasma levels of DDS with a mean half-time of disappearance (T-1/2 of 11.7 hr. No evidence of acetylation of DDS to monoacetyl DDS (MADDS) was found. An equimolar dose of MADDS was deacetylated slowly to DDS by the same dogs. The mean T 1/2 of MADDS was 6.5 hr, significantly less than that of DDS. In 2-hr plasma samples after these doses of drugs, protein-binding of DDS and MADDS averaged 71 and 84%, respectively. Tests of protein-binding of the two drugs in vitro confirmed the observations in vivo.

摘要

四只接受1.0毫克/千克氨苯砜(DDS)静脉注射的雌性犬,其血浆中DDS水平呈对数下降,平均消失半衰期(T-1/2)为11.7小时。未发现DDS乙酰化为单乙酰氨苯砜(MADDS)的证据。相同的犬将等摩尔剂量的MADDS缓慢脱乙酰化为DDS。MADDS的平均T 1/2为6.5小时,显著短于DDS的T 1/2。在这些药物剂量后的2小时血浆样本中,DDS和MADDS的蛋白结合率分别平均为71%和84%。两种药物的体外蛋白结合试验证实了体内观察结果。

相似文献

1
The disposition of dapsone and monoacetyldapsone in the dog (38516).氨苯砜和单乙酰氨苯砜在犬体内的处置(38516)
Proc Soc Exp Biol Med. 1975 Jan;148(1):251-5. doi: 10.3181/00379727-148-38516.
2
Disposition of dapsone and monoacetyldapsone in rats.
Proc Soc Exp Biol Med. 1975 Nov;150(2):485-92. doi: 10.3181/00379727-150-39062.
3
The pharmacokinetics of dapsone and acetylated dapsone in serum and saliva.氨苯砜及乙酰化氨苯砜在血清和唾液中的药代动力学。
Int J Clin Pharmacol Biopharm. 1979 Apr;17(4):159-63.
4
Renal and biliary disposition of dapsone in the dog.氨苯砜在犬体内的肾脏和胆汁排泄情况。
Antimicrob Agents Chemother. 1975 Jun;7(6):816-24. doi: 10.1128/AAC.7.6.816.
5
Dapsone in saliva and plasma of man.人唾液和血浆中的氨苯砜。
Pharmacology. 1981;22(3):162-71. doi: 10.1159/000137486.
6
N-acetylation polymorphism of dapsone in a Japanese population.日本人群中氨苯砜的N-乙酰化多态性
Br J Clin Pharmacol. 1988 Apr;25(4):487-94. doi: 10.1111/j.1365-2125.1988.tb03333.x.
7
N-acetylation phenotyping using dapsone in a Jordanian population.在约旦人群中使用氨苯砜进行N-乙酰化表型分析。
Br J Clin Pharmacol. 1991 Sep;32(3):289-93. doi: 10.1111/j.1365-2125.1991.tb03901.x.
8
Pharmacokinetic observations on dapsone in dermatitis herpetiformis.疱疹样皮炎中氨苯砜的药代动力学观察。
Br J Dermatol. 1983 Jan;108(1):91-8. doi: 10.1111/j.1365-2133.1983.tb04583.x.
9
N-acetylation phenotyping with dapsone in a mainland Chinese population.中国大陆人群中使用氨苯砜的N-乙酰化表型分析。
Br J Clin Pharmacol. 1988 Jan;25(1):81-7. doi: 10.1111/j.1365-2125.1988.tb03285.x.
10
Plasma dapsone and its metabolite monoacetyldapsone levels in leprotic patients.麻风病患者血浆中氨苯砜及其代谢产物单乙酰氨苯砜的水平。
Int J Clin Pharmacol Ther Toxicol. 1988 Nov;26(11):552-4.

引用本文的文献

1
Renal and biliary disposition of dapsone in the dog.氨苯砜在犬体内的肾脏和胆汁排泄情况。
Antimicrob Agents Chemother. 1975 Jun;7(6):816-24. doi: 10.1128/AAC.7.6.816.